ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 884

Receptor Activator of Nuclear Factor ÊB Ligand-Mediated Osteoclastogenesis Is Augmented by Interleukin-1â Via up-Regulation of Endoplasmic Reticulum Stress Signals

Myong-Joo Hong1, Myung-Soon Sung1, Eun-Gyeong Lee1, Yoon Kyung Hong1, Chang-Hoon Lee2, Myeung Su Lee3 and Wan-Hee Yoo4, 1Rheumatology, Department of Internal Medicine, Chonbuk National University Medical School and Research Institute of Clinical Medicine, Jeonju, South Korea, 2Department of Internal Medicine, School of medicine, Wonkwang university, Iksan, Chonbuk, South Korea, 3Department of Internal Medicine, School of Medicine, Wonkwang University, Iksan, Chonbuk, South Korea, 4Department of Internal Medicine, Chonbuk National University Medical School and Research Institute of Clinical Medicine, Jeonju, South Korea

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Interleukins (IL) and osteoclasts

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Cytokines, Mediators, and Gene Regulation

Session Type: Abstract Submissions (ACR)

Background/Purpose: Interleukin-1β (IL-1β) and thapsigargin (TG)-augmented endoplasmic reticulum (ER) stress modulate the receptor activator of nuclear factor kappa-B ligand (RANKL)-mediated osteoclastogenesis. However, the mechanism by which IL-1β and TG affect osteoclastogenesis remains elusive. Thus, we investigated the relationships between RANKL-mediated osteoclast specific pathways and ER stress relevant signals in osteoclast differentiation of bone marrow-derived cells.

Methods: Bone marrow cells (BMCs) were obtained from 5-week-old male ICR mice. The cells were cultured to be differentiated into osteoclasts with macrophage-colony stimulating factor (M-CSF) and RANKL in the presence or absence of IL-1β, thapsigargin (TG, ER stress inducer), or 4-phenylbutyric acid (PBA, ER stress inhibitor). The formation of osteoclasts was evaluated by tartrate-resistant acid phosphatase (TRAP) staining and resorption pit assay with dentine slice. The molecular mechanisms of IL-1β and ER stress in osteoclastogenesis of BMCs were investigated using reverse transcription-polymerase chain reaction (RT-PCR) and immunoblotting. Osteoclast specific and ER stress relevant signaling molecules were analyzed. Transfections of small interfering RNA (siRNA) for glucose-regulated protein 78 (GRP78), protein kinase RNA-like ER kinase (PERK) and inositol-requiring enzyme 1 (IRE1) were performed to knockdown ER stress initiating signals to verify the relationships between osteoclast specific pathways and ER stress signals.

Results: The formation of osteoclasts was increased by IL-1β and TG augmented ER stress. PBA significantly inhibited IL-1β and TG induced osteoclats formation. The expressions of osteoclast specific pathways such as c-Fos and NFATc1, and ER stress associated signals such as PERK, IRE1, GRP78, and eIF2α were significantly increased by IL-1β and TG which was inhibited by PBA. Inhibition of ER stress initiating signals by siRNA inhibited the expression of above mentioned osteoclast specific signals, thus reduced IL-1β and/or TG-induced osteoclastogenesis.

Conclusion: IL-1β and/or TG-augmented ER stress significantly increased osteoclast formation which was inhibited by PBA. The mechanisms were mainly associated with up-regulation of ER stress signals such as GRP78, PERK, p-eIF2α and IRE1. Thus the modulation of ER stress signals affecting osteoclast formation might be a new therapeutic strategy to prevent inflammatory and destructive arthritis diseases such as rheumatoid arthritis (RA) and diverse osteoporotic diseases.


Disclosure:

M. J. Hong,
None;

M. S. Sung,
None;

E. G. Lee,
None;

Y. K. Hong,
None;

C. H. Lee,
None;

M. S. Lee,
None;

W. H. Yoo,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/receptor-activator-of-nuclear-factor-eb-ligand-mediated-osteoclastogenesis-is-augmented-by-interleukin-1a-via-up-regulation-of-endoplasmic-reticulum-stress-signals/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology